Advertisement

Transgenic Models to Study Diseases of the Nervous System: An In Vivo Approach to Dissect Complex Pathogenetic Networks

  • L. Mucke
Conference paper
  • 22 Downloads

Abstract

Diseases of the nervous system often pose particular challenges, both in terms of their pathogenetic complexity and their refractoriness to conventional therapeutic strategies. Multiple sclerosis, Alzheimer’s disease (AD), and the human immunodeficiency virus 1 (HIV-1) associated cognitive/motor complex dramatically illustrate this point. Because many disease processes that afflict the central nervous system (CNS) evolve slowly, the neuropathologist is often confronted with postmortem material that reflects the intricate combination of causative and compensatory processes. Unfortunately, many features of CNS diseases are also difficult to dissect with in vitro models because of the extensive interactions between different types of predominantly nondividing cells that characterize the adult CNS. Nevertheless, both in vitro models and the pathologic analysis of nervous tissue have provided important leads as to which cellular activities, gene products, infectious agents, or chemical compounds may constitute potential etiologic factors in the development of neurologic illnesses.

Keywords

Major Histocompatibility Complex Glial Fibrillary Acidic Protein Experimental Allergic Encephalomyelitis Transgenic Model Adult Central Nervous System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor alphal-antichymotrypsin in the brain amyloid deposits of Alzheimer’s disease. Cell 52:487–501PubMedCrossRefGoogle Scholar
  2. An G, Hidaka K, Siminovitch L (1982) Expression of bacterial beta-galatosidase in animal cells. Mol Cell Biol 2:1628–1632PubMedGoogle Scholar
  3. Arnold B, Hämmerling GJ (1991) MHC class-I transgenic mice. Annu Rev Immunol 9:297–322PubMedCrossRefGoogle Scholar
  4. Balcarek JM, Cowan NJ (1985) Structure of the mouse glial fibrillary acidic protein gene: implications for the evolution of the intermediate filament multigene family. Nucleic Acids Res 13:5527–5543PubMedCrossRefGoogle Scholar
  5. Bignami A, Dahl D (1976) The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFA) in mammalian and submammalian vertebrates. Neuropathol Appl Neurobiol 2:99–110CrossRefGoogle Scholar
  6. Bignami A, Eng LF, Dahl D, Uyeda CT (1972) Localization of glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res 43:429–435PubMedCrossRefGoogle Scholar
  7. Bonifer C, Vidal M, Grosveld F, Sippel AE (1990) Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J 9:2843–2848PubMedGoogle Scholar
  8. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115–1119PubMedCrossRefGoogle Scholar
  9. Bottazzo GF, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R (1986) Organ-specific autoimmunity: a 1986 overview. Immunol Rev 94:137–169PubMedCrossRefGoogle Scholar
  10. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639–642PubMedCrossRefGoogle Scholar
  11. Brinster RL, Palmiter RD (1986) Introduction of genes into the germline of animals. Harvey Lectures Ser 80:1–38Google Scholar
  12. Brinster RL, Allen JM, Behringer RR, Gelinas RE, Palmiter RD (1988) Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci USA 85:836–840PubMedCrossRefGoogle Scholar
  13. Camenga DL, Johnson KP, Alter M, Engelhardt CD, Fishman PS, Greenstein JI, Haley AS, Hirsch RL, Kleiner JE, Kofie VY, et al (1986) Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis. Arch Neurol 43:1239–1246PubMedGoogle Scholar
  14. Campbell IL, Oldstone MBA, Mucke L (1992) Neurologic disease induced in transgenic mice by the astrocyte-specific expression of interleukin-6. Soc Neurosci Abstr (in press)Google Scholar
  15. Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer’s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353:844–846PubMedCrossRefGoogle Scholar
  16. Choi T, Huang M, Gorman C, Jaenisch R (1991) A generic intron increases gene expression in transgenic mice. Mol Cell Biol 11:3070–3074PubMedGoogle Scholar
  17. De La Monte SM, Ho DD, Schooley RT, Hirsch MS, Richardson EPJr (1987) Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology 37:562–569PubMedGoogle Scholar
  18. Delacourte A (1990) General and dramatic glial reaction in Alzheimer brains. Neurology 40:33–37PubMedGoogle Scholar
  19. Doherty PC, Zinkernagel RM (1974) T-cell-mediated immunopathology in viral infections. Transplant Rev 19:89–120PubMedGoogle Scholar
  20. Fierz W, Endler B, Reske K, Wekerle H, Fontana A (1985) Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 134:3785–3793PubMedGoogle Scholar
  21. Fontana A, Fierz W, Wekerle H (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307:273–276PubMedCrossRefGoogle Scholar
  22. Fontana A, Erb P, Pircher H, Zinkernagel R, Weber E, Fierz W (1986) Astrocytes as antigen-presenting cells. II. Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon gamma. J Neuroimmunol 12:15–28PubMedCrossRefGoogle Scholar
  23. Frohman EM, van den Noort S, Gupta S (1989) Astrocytes and intracerebral immune responses. J Clin Immunol 9:1–9PubMedCrossRefGoogle Scholar
  24. Giulian, D (1987) Ameboid microglia as effectors of inflammation in the central nervous system. J Neurosci Res 18:155–171PubMedCrossRefGoogle Scholar
  25. Giulian D, Vaca K, Noonan CA (1990) Secretion of neurotoxin by mononuclear phagocytes infected with HIV-1. Science 250:1593–1596PubMedCrossRefGoogle Scholar
  26. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706PubMedCrossRefGoogle Scholar
  27. Gordon JW (1986) Transgenic mice in immunology. M Sinai J Med 53:223–231Google Scholar
  28. Hall CV, Jacob PE, Ringold GM, Lee F (1983) Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet 2:101–109PubMedGoogle Scholar
  29. Hickey WF, Osborn JP, Kirby WM (1985) Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol 91:528–535PubMedCrossRefGoogle Scholar
  30. Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28:254–260PubMedCrossRefGoogle Scholar
  31. Hogan B, Costantini F, Lacy E (1986) Manipulating the mouse embryo. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring HarborGoogle Scholar
  32. Janeway CAJr, Bottomly K, Babich J, Conrad P, Conzen S, Jones B, Kaye J, Katz M, McVay L, Murphy DB, Tite J (1984) Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol Today 5:99–105CrossRefGoogle Scholar
  33. Johnson KP (1988) Treatment of multiple sclerosis with various interferons: the cons Neurology 38:62–65Google Scholar
  34. Kimelberg HK, Norenberg MD (1989) Astrocytes Sci Am 66–76Google Scholar
  35. Knobler RL, Panitch HS, Braheny SL, Sipe JC, Rice GP, Huddlestone JR, Francis GS, Hooper CK, Kamin Lewis RM, Johnson KP, et al (1984) Systemic alpha-interferon therapy of multiple sclerosis. Neurology 34:1273–1279PubMedGoogle Scholar
  36. Lassmann H, Zimprich F,Vass K, Hickey WF (1991) Microglial cells are a component of the perivascular glia limitans. J Neurosci Res 28:236–243PubMedCrossRefGoogle Scholar
  37. Lewis SA, Balcarek JM, Krek V, Shelanski M, Cowan NJ (1984) Sequence of a cDNA clone encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. Proc Natl Acad Sci USA 81:2743–2746PubMedCrossRefGoogle Scholar
  38. Lieberman AP, Ptha PM, Shin HS, Shin ML (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86:6348–6352PubMedCrossRefGoogle Scholar
  39. Lipton SA (1992) Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci 15:75–79PubMedCrossRefGoogle Scholar
  40. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111–118PubMedCrossRefGoogle Scholar
  41. Male DK, Pryce G, Hughes CC (1987) Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. Immunology 60:453–459PubMedGoogle Scholar
  42. Massa PT, ter Meulen V (1987) Analysis of Ia induction on Lewis rat astrocytes in vitro by virus particles and bacterial adjuvants. J Neuroimmunol 13:259–271PubMedCrossRefGoogle Scholar
  43. Massa PT, Brinkmann R, ter Meulen V (1987) Inducibility of Ia antigen on astrocytes by murine Coronavirus JHM is rat strain dependent. J Exp Med 166:259–264PubMedCrossRefGoogle Scholar
  44. Merlino GT (1991) Transgenic animals in biomedical research. FASEB J 5:2996–3001PubMedGoogle Scholar
  45. Mucke L, Oldstone MBA, Morris JC, Nerenberg MI (1991) Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biologist 3:465–474PubMedGoogle Scholar
  46. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254:97–99PubMedCrossRefGoogle Scholar
  47. Navia BA, Price RW (1987) The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 44:65–69PubMedGoogle Scholar
  48. Navia BA, Cho ES, Petito CK, Price RW (1986) The AIDS dementia complex. II. Neuropathology Ann Neurol 19:525–535PubMedCrossRefGoogle Scholar
  49. Palmiter RD, Brinster RL (1986) Germ-line transformation of mice. Annu Rev Genet 20:465–499PubMedCrossRefGoogle Scholar
  50. Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL (1991) Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci USA 88:478–482PubMedCrossRefGoogle Scholar
  51. Price RW, Brew BJ (1988) The AIDS dementia complex. J Infect Dis 158: 1079–1083PubMedCrossRefGoogle Scholar
  52. Prusiner SB (1991) Molecular biology and transgenetics of prion diseases. Crit Rev Biochem Mol Biol 26:397–438PubMedCrossRefGoogle Scholar
  53. Ren R, Racaniello VR (1992) Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 66:296–304PubMedGoogle Scholar
  54. Ren RB, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR (1990) Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353–362PubMedCrossRefGoogle Scholar
  55. Sanes JR, Rubenstein JLR, Nicolas J-F (1986) Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 5:3133–3142PubMedGoogle Scholar
  56. Selkoe DJ (1991a) The molecular pathology of Alzheimer’s disease. Neuron 6:487–496PubMedCrossRefGoogle Scholar
  57. Selkoe DJ (1991b) Amyloid protein in Alzheimer’s disease. Sci Am 11:68–78CrossRefGoogle Scholar
  58. Skias DD, Kim D-K, Reder AT, Antel JP, Lancki DW, Fitch FW (1987) Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J Immunol 138:3254–3258PubMedGoogle Scholar
  59. Smith ME, Somera FP, Eng LF (1983) Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis. Brain Res 264:241–253PubMedCrossRefGoogle Scholar
  60. Suzumura A, Lavi E, Weiss SR, Silberberg DH (1986) Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 232:991–993PubMedCrossRefGoogle Scholar
  61. Suzumura A, Lavi E, Bhat S, Murasko D, Weiss SR, Silberberg DH (1988) Induction of glial cell MHC antigen expression in neurotropic Coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. J Immunol 140:2068–2072PubMedGoogle Scholar
  62. Swain JL, Stewart TA, Leder P (1987) Parental legacy determines methylation and expression of an autosomal transgene: a molecular mechanism for parental imprinting. Cell 50:719–727PubMedCrossRefGoogle Scholar
  63. Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9:271–277CrossRefGoogle Scholar
  64. Wekerle H, Sun D, Oropeza-Wekerle RL, Meyermann R (1987) Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J Exp Biol 132:43–57PubMedGoogle Scholar
  65. Wilson C (1990) Position effects on eukaryotic gene expression. Annu Rev Cell Biol 6:679–714PubMedCrossRefGoogle Scholar
  66. Wong GH, Bartlett PF, Clark Lewis I, Battye F, Schrader JW (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310:688–691PubMedCrossRefGoogle Scholar
  67. Working Group of the American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41:778–785Google Scholar
  68. Yankner BA, Mesulam M-M (1991) Beta-amyloid and the pathogenesis of Alzheimer’s disease. N Engl J Med 325:1849–1857PubMedCrossRefGoogle Scholar
  69. Zinkernagel RM, Doherty PC (1974) Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248:701PubMedCrossRefGoogle Scholar
  70. Zinkernagel RM, Doherty PC (1983) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function, and responsiveness. Adv Immunol 27:51–77CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • L. Mucke

There are no affiliations available

Personalised recommendations